SD Biosensor (137310 KS): COVID Test Revenue Tapering Off; Global Expansion to Drive Future Growth
SD Biosensor is expected to take massive hit in revenue in 2023 due to declining COVID tests. However, new product launches and global expansion...
637 Views
Bionote Lock-Up - Uncertainty on the Horizon, Likely to See Some Selling Pressure
Bionote (377740 KS) was listed on 22nd Dec 2023, when it raised US$73m in its downsized Korean IPO. Its three-month lockup will expire on 21st Mar 23.
529 Views
Bionote IPO Trading - Weakest Demand Even After Cutting Price and Size
Bionote (377740 KS) raised US$72.2m in its Korean IPO. In this note, we will talk about the demand for the deal and other trading dynamics.
852 Views
Bionote Pre-IPO Peer Comp - Larger Segment Leads in Margins, but Trend Could Be Reversing
Bionote is looking to raise approximately US$200m in its Korean IPO. The IPO would consist of both a primary and secondary selldown. In this note,...
371 Views
BioNote IPO Valuation Analysis
Our base case valuation is target price of 16,182 won per share, which is 10% lower than the low end of the IPO price range.
374 Views